About half of 215 surveyed members of the Society of Breast Imaging already use FDA-approved AI tools for breast cancer detection, but the results fall short of expectations. Only 35 percent report lower recall rates, w…
New models reset the capability and price-performance frontier. Teams re-evaluate what to build on whenever a launch shifts what's possible per dollar.
Summaries are aggregated for information only — follow the source link for the full story. Demo entries are illustrative.